{"schema_version":"1","generated_at":"2026-11-19T01:07:33.359Z","data_as_of":null,"url":"https://www.findmykol.com/kol/marissa-rybstein","json_url":"https://www.findmykol.com/kol/marissa-rybstein/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"marissa-rybstein","name":"Marissa Rybstein","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"NYU Langone Health","institution_url":"https://www.findmykol.com/institution/nyu-langone-health","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1447593132","openalex":"A5080365406"},"summary":"Marissa Rybstein is a Hematology physician affiliated with NYU Langone Health. OpenAlex indexes 21 publications with 867 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":21,"cited_by_count":867,"h_index":7,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Merck & Co.","program_year":2025,"amount_usd":117446.87,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447593132"},{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":31.34,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447593132"},{"payer":"Merck & Co.","program_year":2024,"amount_usd":418676.31,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447593132"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1447593132","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":30.6,"classes_total":5,"classes":[{"class":"Benzodiazepine","setting":"prescribed","share_pct":9.5,"drugs":[{"name":"Alprazolam","share_pct":56.2},{"name":"Clonazepam","share_pct":43.8}],"max_beneficiaries":null},{"class":"Opioid Agonist","setting":"prescribed","share_pct":7.4,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":18}]},{"area":"Metabolism & gastrointestinal","share_pct":25.8,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":14.5,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":31},{"class":"Corticosteroid","setting":"prescribed","share_pct":5.9,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":20.2,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":20.2,"drugs":[{"name":"Eliquis","share_pct":70.6},{"name":"Xarelto","share_pct":29.4}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":85.5,"facility_pct":14.5},"source":"medicare"},"publications":{"total":21,"shown":5,"withheld":16,"matched_by":"OpenAlex author record","recent":[{"title":"Efficacy, safety, and cytokine profiling with addition of the toll-like receptor (TLR) 7/8 dual agonist EIK1001 to standard of care (SOC) first-line (1L) therapy: The phase 2 TeLuRide-005 trial in stage 4 NSCLC.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.8568","status":"verified"},{"title":"A phase 2/3 study of EIK1001 in combination with pembrolizumab and chemotherapy in participants with stage 4 non–small cell lung cancer (NSCLC) (TeLuRide-008).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.tps8668","status":"verified"},{"title":"A Phase 2 Exploratory Trial Evaluating Computed Tomography–Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer","year":2025,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2025.09.054","status":"verified"},{"title":"Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapy","year":2023,"journal":"Acta Oncologica","source_url":"https://doi.org/10.1080/0284186x.2023.2177973","status":"verified"},{"title":"Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapy","year":2023,"journal":"Figshare","source_url":"https://doi.org/10.6084/m9.figshare.22100578","status":"verified"}],"source":"works"},"contact":{"address_1":"520 E 70TH ST # 341","city":"New York","state":"NY","zip":"100219800","phone":"212-746-2061","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1447593132","source":"identity"},"similar":[{"name":"Gareth Morgan","slug":"gareth-morgan","institution":"NYU Langone Health","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gareth-morgan","json_url":"https://www.findmykol.com/kol/gareth-morgan/profile.json"},{"name":"Ira Jacobson","slug":"ira-jacobson","institution":"NYU Langone Health","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/ira-jacobson","json_url":"https://www.findmykol.com/kol/ira-jacobson/profile.json"},{"name":"Faith Davies","slug":"faith-davies","institution":"NYU Langone Health","specialty":"Hematology","url":"https://www.findmykol.com/kol/faith-davies","json_url":"https://www.findmykol.com/kol/faith-davies/profile.json"},{"name":"Michael Zelefsky","slug":"michael-zelefsky","institution":"NYU Langone Health","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/michael-zelefsky","json_url":"https://www.findmykol.com/kol/michael-zelefsky/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":16}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-09-12","provider_certified":"2022-09-12","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}